LOADING
Comparing AbbVie Inc (ABBV) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $433.0B | $307.2B |
| P/E Ratio | 69.2 | 36.0 |
| Forward P/E | 17.8 | 48.3 |
| PEG Ratio | 0.41 | 12.06 |
| EPS | $3.54 | $3.55 |
| Revenue Growth (YoY) | 10.2% | 4.9% |
| Profit Margin | 9.8% | 13.6% |
| Return on Equity | 62.3% | 18.9% |
| Dividend Yield | 1.34% | 2.52% |
| Beta | 0.28 | 0.21 |
| 52-Week High | $267.47 | $135.05 |
| 52-Week Low | $188.81 | $75.81 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.